{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T18:34:29Z","timestamp":1778178869727,"version":"3.51.4"},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T00:00:00Z","timestamp":1728518400000},"content-version":"am","delay-in-days":405,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.therap.2023.03.005","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T10:31:30Z","timestamp":1678530690000},"page":"499-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)"],"prefix":"10.1016","volume":"78","author":[{"given":"Marie-Blanche","family":"Valnet-Rabier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Tebacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joelle","family":"Micallef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Salvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Pariente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.therap.2023.03.005_bib0320","series-title":"R\u00e9seau fran\u00e7ais des centres r\u00e9gionaux de pharmacovigilance.","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0325","first-page":"n958","article-title":"COVID-19 post-vaccine menorrhagia, metrorrhagia or postmenopausal bleeding and potential risk of vaccine-induced thrombocytopenia in women","volume":"373","author":"Merchant","year":"2021","journal-title":"BMJ"},{"issue":"28","key":"10.1016\/j.therap.2023.03.005_bib0330","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm7201","article-title":"Investigating trends in those experience menstrual bleeding changes after SARS-CoV-2","volume":"8","author":"Lee","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.therap.2023.03.005_bib0335","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.ajog.2020.06.004","article-title":"Menstruation: science and society","volume":"223","author":"Critchley","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.therap.2023.03.005_bib0340","doi-asserted-by":"crossref","first-page":"305","DOI":"10.4236\/ojog.2015.56044","article-title":"Is premenstrual syndrome a uterine inflammatory disease? Retrospective evaluation of an etiologic approach","volume":"5","author":"Lolas-Talhami","year":"2015","journal-title":"Open J Obstet Gynecol"},{"key":"10.1016\/j.therap.2023.03.005_bib0345","first-page":"21","article-title":"Menstruation, inflammation and comorbidities: implications for woman health","volume":"67","author":"Graziottin","year":"2015","journal-title":"Minerva Ginecol"},{"key":"10.1016\/j.therap.2023.03.005_bib0350","series-title":"Point de situation sur la surveillance des vaccins contre la COVID-19\u202f: p\u00e9riode du 23\/7\/2021 au 29\/07\/2021.","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM).","year":"2021"},{"key":"10.1016\/j.therap.2023.03.005_bib0355","series-title":"Troubles menstruels apr\u00e8s la vaccination contre le COVID-19: \u00e9tat des connaissances et conseils aux femmes concern\u00e9s","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM).","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0360","first-page":"283","article-title":"Autoanticorps dirig\u00e9s contre le facteur VIII\u00a0: \u00ab\u00a0h\u00e9mophilie acquise\u00a0\u00bb\u00a0: r\u00e9f\u00e9rentiels h\u00e9mostase\/Soci\u00e9t\u00e9 fran\u00e7aise d\u2019h\u00e9matologie\/Groupe d\u2019\u00e9tude sur l\u2019h\u00e9mostase et la thrombose","volume":"18","author":"Trossa\u00ebrt","year":"2012","journal-title":"H\u00e9matologie"},{"key":"10.1016\/j.therap.2023.03.005_bib0365","series-title":"Analyse et expertise des cas d\u2019auto-anticorps dirig\u00e9s contre le facteur VIII (h\u00e9mophilie acquise)","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0370","article-title":"Troubles inflammatoires \u00e0 type d\u2019an\u00e9mie h\u00e9molytique autoimmune et d\u2019h\u00e9mophilie acquise","volume":"5","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022","journal-title":"Focus mensuel"},{"key":"10.1016\/j.therap.2023.03.005_bib0375","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.therap.2023.03.005_bib0380","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1007\/s00228-010-0852-z","article-title":"Acquired factor VIII haemophilia following influenza vaccination","volume":"66","author":"Moulis","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.therap.2023.03.005_bib0385","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2516.2011.02493.x","article-title":"A case of acquired haemophilia following H1N1 vaccination","volume":"17","author":"Pirrotta","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.therap.2023.03.005_bib0390","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/jth.15291","article-title":"A case report of acquired hemophilia following COVID-19 vaccine","volume":"19","author":"Radwi","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.therap.2023.03.005_bib0395","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1177\/10781552221075545","article-title":"Acquired hemophilia a following Pfizer-BioNTech SARS CoV-2 mRNA vaccine, successfully treated with prednisolone and rituximab","volume":"28","author":"Murali","year":"2022","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.therap.2023.03.005_bib0400","first-page":"e21909","article-title":"Acquired hemophilia A post-COVID-19 vaccination: a case report and review","volume":"14","author":"Al Hennawi","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.therap.2023.03.005_bib0405","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.thromres.2022.01.017","article-title":"Four cases of acquired hemophilia A following immunization with mRNA BNT162b2 SARS-CoV-2 vaccine","volume":"211","author":"Leone","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.therap.2023.03.005_bib0410","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1055\/a-1579-5396","article-title":"Autoimmunity after coronavirus disease 2019 (COVID-19) vaccine: a case of acquired hemophilia A","volume":"121","author":"Farley","year":"2021","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.therap.2023.03.005_bib0415","doi-asserted-by":"crossref","first-page":"e246922","DOI":"10.1136\/bcr-2021-246922","article-title":"Case of acquired haemophilia a in Southeast Asia following COVID-19 vaccine","volume":"15","author":"Ai Vuen","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.therap.2023.03.005_bib0420","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1016\/j.jfma.2022.02.017","article-title":"A case of acquired hemophilia A and bullous pemphigoid following SARS-CoV-2 mRNA vaccination","volume":"121","author":"Fu","year":"2022","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.therap.2023.03.005_bib0425","first-page":"683","article-title":"Acquired hemophilia A after vaccination against SARS-CoV-2 with the mRNA-1273 (Moderna) vaccine","volume":"35","author":"Melmed","year":"2022","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.therap.2023.03.005_bib0430","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1002\/ajh.25865","article-title":"The first case of acquired hemophilia A associated with SARS-CoV infection","volume":"95","author":"Franchini","year":"2020","journal-title":"Am J Hematol."},{"key":"10.1016\/j.therap.2023.03.005_bib0435","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1111\/trf.16254","article-title":"De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection","volume":"61","author":"Olsen","year":"2020","journal-title":"Transfusion"},{"key":"10.1016\/j.therap.2023.03.005_bib0440","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/jth.15665","article-title":"Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines","volume":"20","author":"Hirsiger","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.therap.2023.03.005_bib0445","series-title":"Syndrome de Parsonage Turner (n\u00e9vralgie amyotrophiante)","author":"Legre","year":"2009"},{"key":"10.1016\/j.therap.2023.03.005_bib0450","series-title":"Analyse et expertise des cas de syndrome de, Parsonage-Turner. Rapport no 20.","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0455","series-title":"Syndrome de Parsonage-Turner. Rapport no\u00a015","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2021"},{"key":"10.1016\/j.therap.2023.03.005_bib0460","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1002\/mus.27255","article-title":"Parsonage Turner syndrome after COVID-19 vaccination","volume":"64","author":"Mahajan","year":"2021","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.therap.2023.03.005_bib0465","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1148\/radiol.2021211374","article-title":"Parsonage-Turner syndrome following COVID-19 vaccination: MR neurography","volume":"302","author":"Queler","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.therap.2023.03.005_bib0470","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/pmrj.12619","article-title":"Painless idiopathic neuralgic amyotrophy after COVID1-19 vaccination. A case report","volume":"14","author":"Diaz-Segarra","year":"2022","journal-title":"PM R"},{"key":"10.1016\/j.therap.2023.03.005_bib0475","doi-asserted-by":"crossref","DOI":"10.2106\/JBJS.CC.21.00370","article-title":"Parsonage-Turner syndrome after SARS-CoV-2 BNT162b2 vaccine","volume":"11","author":"Coffman","year":"2021","journal-title":"JBJS Case Connect"},{"key":"10.1016\/j.therap.2023.03.005_bib0480","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000521462","article-title":"Parsonage-Turner syndrome following COVID-19 vaccination: clinical and electromyographic findings in 6 patients","volume":"14","author":"Shields","year":"2022","journal-title":"Case Rep Neurol"},{"key":"10.1016\/j.therap.2023.03.005_bib0485","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/qjmed\/hcab216","article-title":"Neuralgic amyotrophy following COVID-19 mRNA vaccination","volume":"114","author":"Koh","year":"2021","journal-title":"QJM"},{"key":"10.1016\/j.therap.2023.03.005_bib0490","series-title":"Analyse et expertise des cas de pseudo-polyarthrite rhizom\u00e9lique (PPR). Rapport no\u00a019","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0495","series-title":"Analyse et expertise des cas de vascularite. Rapport p\u00e9riodique no\u00a01","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0500","doi-asserted-by":"crossref","first-page":"105282","DOI":"10.1016\/j.jbspin.2021.105282","article-title":"SARS-CoV 2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: \u201cCan SARS-CoV-2 trigger relapse of polymyalgia rheumatica?\u201d by Manzo et al.","volume":"89","author":"Cadiou","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.therap.2023.03.005_bib0505","doi-asserted-by":"crossref","first-page":"105284","DOI":"10.1016\/j.jbspin.2021.105284","article-title":"Answer to Cadiou et al. \u201cSARS-CoV 2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger?\u201d","volume":"89","author":"Manzo","year":"2021","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.therap.2023.03.005_bib0510","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.therap.2023.03.005_bib0515","series-title":"Analyse p\u00e9riodique no\u00a03 Comirnaty\u00ae","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0520","series-title":"Analyse p\u00e9riodique no\u00a03 Spikevax\u00ae","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0525","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijid.2021.10.025","article-title":"Sudden sensorineuronal hearing loss after COVID-19 vaccination","volume":"113","author":"Jeong","year":"2021","journal-title":"Int J Infect Diseases"},{"key":"10.1016\/j.therap.2023.03.005_bib0530","first-page":"1","article-title":"Four cases of audio-vestibular disorders related to immunisation with SARS COV2 mRNA vaccine","volume":"5","author":"Ekobena","year":"2022","journal-title":"Int J Audiol"},{"key":"10.1016\/j.therap.2023.03.005_bib0535","doi-asserted-by":"crossref","first-page":"e1213","DOI":"10.1097\/MAO.0000000000003275","article-title":"Otologic manifestations after COVID-19 vaccination: the house ear clinic experience","volume":"42","author":"Wishova","year":"2021","journal-title":"Otol Neurotol"},{"key":"10.1016\/j.therap.2023.03.005_bib0540","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1001\/jamaoto.2021.4414","article-title":"Assessment of sudden sensorineural hearing loss after COVID-19 vaccination","volume":"148","author":"Formeister","year":"2022","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.therap.2023.03.005_bib0545","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jamaoto.2021.0869","article-title":"Preliminary analysis of association between COVID-19 vaccination and Sudden hearing loss using US Centers for Disease Control and prevention vaccine adverse events reporting system data","volume":"147","author":"Formeister","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.therap.2023.03.005_bib0550","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jamaoto.2021.4278","article-title":"Association between the BNT162b2 Messenger RNA vaccine and Sudden hearing loss","volume":"148","author":"Yanir","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.therap.2023.03.005_bib0555","series-title":"Analyse et expertise des cas d\u2019hypertension art\u00e9rielle.","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2021"},{"key":"10.1016\/j.therap.2023.03.005_bib0560","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Analyse et expertise des cas graves de la pression art\u00e9rielle. https:\/\/ansm.sante.fr\/uploads\/2021\/05\/07\/20210506-rapport-comirnaty-9-vfa.pdf [Accessed 7 March 2023]."},{"key":"10.1016\/j.therap.2023.03.005_bib0565","series-title":"Analyse et expertise des cas graves de la pression art\u00e9rielle","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2021"},{"key":"10.1016\/j.therap.2023.03.005_bib0570","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coph.2014.12.003","article-title":"Role of T lymphocytes in hypertension","volume":"21","author":"Zhang","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.therap.2023.03.005_bib0575","article-title":"Aldosterone, inflammation, immune system and hypertension","author":"Ferreira","year":"2020","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.therap.2023.03.005_bib0580","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2023.03.005_bib0585","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2023.03.005_bib0590","article-title":"Acute and subacute, and Riedel\u2019s thyroiditis. [Updated 2015 Dec 8]. Endotext Internet South Dartm MA MDText","author":"Majety","year":"2000","journal-title":"Com Inc"},{"key":"10.1016\/j.therap.2023.03.005_bib0595","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1056\/NEJMra021194","article-title":"Thyroiditis","volume":"348","author":"Pearce","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.therap.2023.03.005_bib0600","series-title":"Focus mensuel situations sp\u00e9cifiques n\u00a04. Thyro\u00efdites","author":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM)","year":"2022"},{"key":"10.1016\/j.therap.2023.03.005_bib0605","doi-asserted-by":"crossref","first-page":"100136","DOI":"10.1016\/j.metop.2021.100136","article-title":"Thyroiditis following vaccination against COVID-19: report of two cases and review of the literature","volume":"12","author":"Siolos","year":"2021","journal-title":"Metabol Open"},{"key":"10.1016\/j.therap.2023.03.005_bib0610","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s12020-021-02898-5","article-title":"Thyrotoxicosis after COVID-19 vaccination: seven case reports and a literature review","volume":"74","author":"Lee","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/j.therap.2023.03.005_bib0615","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40618-021-01681-7","article-title":"Post-COVID-vaccine autoimmune\/inflammatory syndrome in response to adjuvants (ASIA syndrome) manifesting as subacute thyroiditis","volume":"45","author":"Das","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.therap.2023.03.005_bib0620","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s40618-020-01436-w","article-title":"Detection of SARS-Cov-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis","volume":"44","author":"Rotondi","year":"2021","journal-title":"J Clin Endocrinol Invest"},{"key":"10.1016\/j.therap.2023.03.005_bib0625","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/cen.14555","article-title":"Can COVID-19 immunisation cause subacute throiditis?","volume":"97","author":"Ratnayake","year":"2021","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.therap.2023.03.005_bib0630","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/imj.15432","article-title":"Risk factors, treatment and outcomes of subacute thyroiditis secondary to COVID-19: a systematic review","volume":"52","author":"Christensen","year":"2022","journal-title":"Intern Med J"}],"container-title":["Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723000549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595723000549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T18:56:46Z","timestamp":1758567406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595723000549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0040595723000549"],"URL":"https:\/\/doi.org\/10.1016\/j.therap.2023.03.005","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)","name":"articletitle","label":"Article Title"},{"value":"Therapies","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.therap.2023.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de pharmacologie et de th\u00e9rapeutique. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}